Standout Papers
Citation Impact
Citing Papers
Modulation of immune cell reactivity with cis -binding Siglec agonists
2021 StandoutNobel
Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota
2012 StandoutScience
Cancer risk in patients with rheumatoid arthritis treated with anti–tumor necrosis factor α therapies: Does the risk change with the time since start of treatment?
2009
Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis
2017
Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment
2010
Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety
2008
Interstitial Lung Disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases
2014
Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis
2009
Autoimmune Diseases Induced by TNF-Targeted Therapies
2007
A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer
2008
High prevalence of psoriatic arthritis in dermatological patients with psoriasis: a cross-sectional study
2013
The economics of treatment in early rheumatoid arthritis
2009
The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events
2008
Rheumatoid arthritis
2018 Standout
Psoriasis
2009 Standout
A systematic review and meta‐analysis comparing complications following total joint arthroplasty for rheumatoid arthritis versus for osteoarthritis
2012
Rheumatoid arthritis
2016 Standout
Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin–Yang interplay between inflammation and cancer
2010
Ulcerative Colitis
2011 Standout
Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study
2010
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents
2009
Prosthetic Joint Infection Risk After Total Hip Arthroplasty in the Medicare Population
2009
The tumor-promoting actions of TNF-α involve TNFR1 and IL-17 in ovarian cancer in mice and humans
2009
Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs
2011
Infections and IBD
2008
Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper
2017
Management of Acute and Recurrent Gout: A Clinical Practice Guideline From the American College of Physicians
2016
Guidelines for the management of inflammatory bowel disease in adults
2011
Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis
2008
Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells
2008
Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial
2007
Trial of Tocilizumab in Giant-Cell Arteritis
2017 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Alterations of the synovial T cell repertoire in anti–citrullinated protein antibody–positive rheumatoid arthritis
2009
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Crohn's disease
2012 Standout
A review of stimuli-responsive nanocarriers for drug and gene delivery
2008 Standout
Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study
2006
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register
2008
Influence of anti–tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for rheumatology biologics register
2010
The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
2009
Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials
2008
Psoriasis
2021 Standout
Inflammatory bowel disease: cause and immunobiology
2007 Standout
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Psoriasis: Which therapy for which patient
2018
Optimizing the safety of biologic therapy for IBD
2010
Inflammatory Bowel Disease
2009 Standout
Serious Adverse Events With Infliximab: Analysis of Spontaneously Reported Adverse Events
2007
Osteoarthritis
2015 Standout
Thiopurine-Induced Myelotoxicity in Patients With Inflammatory Bowel Disease: A Review
2008
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
2007
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Asthma
2017 Standout
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Psoriasis
2015 Standout
Clinical features of polymyalgia rheumatica and giant cell arteritis
2012
The natural history of progressive fibrosing interstitial lung diseases
2019
Dermatological complications and safety of anti-TNF treatments
2009
Ulcerative colitis
2012 Standout
Use of the T-SPOT.TB Assay to Detect Latent Tuberculosis Infection Among Rheumatic Disease Patients on Immunosuppressive Therapy
2009
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
2014
The pathogenesis of psoriatic arthritis
2018
The development of allergic inflammation
2008 StandoutNature
Crohn's disease
2016 Standout
Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis
2012
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
American Gastroenterological Association Consensus Development Conference on the Use of Biologics in the Treatment of Inflammatory Bowel Disease, June 21–23, 2006
2007
Gout
2016 Standout
Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
2010
Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: A literature review and potential mechanisms of action
2008
Immunity, Inflammation, and Cancer
2010 Standout
Robust enumeration of cell subsets from tissue expression profiles
2015 Standout
Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study
2008
Frequency, phenotype, outcome, and therapeutic impact of skin reactions following initiation of adalimumab therapy: Experience from a consecutive cohort of inflammatory bowel disease patients
2011
Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment
2008
TNFα blockade in human diseases: An overview of efficacy and safety
2007
Age-related macular degeneration
2018 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis
2009
Diagnostic accuracy of dual-energy computed tomography in patients with gout: A meta-analysis
2017
Ulcerative colitis
2016 Standout
Regulation of tumour necrosis factor signalling: live or let die
2015
Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT
2010
Effect of Infliximab on Short-Term Complications in Patients Undergoing Operation for Chronic Ulcerative Colitis
2007
Acute Infection of Total Knee Arthroplasty Due to a Cat Scratch in a Patient With Rheumatoid Arthritis
2012
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
2010
Rheumatoid arthritis
2010 Standout
BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies
2010
Adverse Events Associated With Common Therapy Regimens for Moderate-to-Severe Crohn's Disease
2009
Macrophage plasticity and polarization: in vivo veritas
2012 Standout
What We Talk About When We Talk About Fat
2014 Standout
At the crossroads of gout and psoriatic arthritis: “psout”
2020
Signs of immune activation and local inflammation are present in the bronchial tissue of patients with untreated early rheumatoid arthritis
2015
Tumour necrosis factor and cancer
2009
Imaging modalities for the classification of gout: systematic literature review and meta-analysis
2014
Lymphoma risk in inflammatory bowel disease: Is it the disease or its treatment?
2007
Inflammation and its role in age-related macular degeneration
2016
Complications and features after joint surgery in rheumatoid arthritis patients treated with tumour necrosis factor- blockers: perioperative interruption of tumour necrosis factor- blockers decreases complications?
2009
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Tumor necrosis factor‐α antagonists and neuropathy
2007
Cancer-related inflammation
2008 StandoutNature
Display technologies: Application for the discovery of drug and gene delivery agents☆
2006
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
The Broad Spectrum of Urate Crystal Deposition: Unusual Presentations of Gouty Tophi
2012
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
A consensus document for the selection of lung transplant candidates: 2014—An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation
2014 Standout
Incidence of Lymphoma in Patients with Rheumatoid Arthritis: A Systematic Review of the Literature
2008
Cancer-related inflammation: Common themes and therapeutic opportunities
2011
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Ocular delivery of proteins and peptides: Challenges and novel formulation approaches
2018
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics
2008
Comorbidities in rheumatoid arthritis
2007
Targeting TNF-α: A novel therapeutic approach for asthma
2007
Hepatosplenic T‐cell lymphoma following infliximab therapy for Crohn's disease
2008
Psoralen and Ultraviolet A Light Therapy for Psoriasis
2007
Safety of T-cell co-stimulation modulation with abatacept in patients with rheumatoid arthritis.
2008
Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
2013 Science
Fat and Beyond: The Diverse Biology of PPARγ
2008 Standout
Rheumatoid Arthritis and Mortality Among Women During 36 Years of Prospective Follow‐Up: Results From the Nurses’ Health Study
2015
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
2019 Standout
Gout
2021 Standout
Prosthetic Joint Infection
2014 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Adalimumab Induction Therapy for Crohn Disease Previously Treated with Infliximab
2007
Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials
2008
Anti-Inflammatory and Proresolving Lipid Mediators
2008
Immunity to Citrullinated Proteins in Rheumatoid Arthritis
2008
Dual-Energy CT: A Promising New Technique for Assessment of the Musculoskeletal System
2012
Idiopathic Pulmonary Fibrosis
2018 Standout
Works of Tim Bongartz being referenced
Citrullinated proteins in rheumatoid arthritis: Crucial … but not sufficient!
2006
Citrullination in extra-articular manifestations of rheumatoid arthritis
2006
Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials
2008
Morphologic and quantitative assessment of CD20+ B cell infiltrates in rheumatoid arthritis–associated nonspecific interstitial pneumonia and usual interstitial pneumonia
2006
Large-vessel involvement in giant cell arteritis
2005
GEPARD-Patientenfragebogen
2009
Dual-energy CT for the diagnosis of gout: an accuracy and diagnostic yield study
2014
Identification of Intraarticular and Periarticular Uric Acid Crystals with Dual-Energy CT: Initial Evaluation
2011
Perioperative care for patients with rheumatic diseases
2011
Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population‐based study
2010
Successful treatment of psoriatic onycho‐pachydermo periostitis (POPP) with adalimumab
2005
Tumor necrosis factor α drives cadherin 11 expression in rheumatoid inflammation
2008
Impact of Thiopurine Methyltransferase Activity and 6‐Thioguanine Nucleotide Concentrations in Patients with Chronic Inflammatory Diseases
2006
Treatment of active psoriatic arthritis with the PPAR ligand pioglitazone: an open-label pilot study
2004
Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis
2008
Malignancy and biologic therapy in rheumatoid arthritis
2008
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
2006 Standout
CD56‐expressing T cells that have features of senescence are expanded in rheumatoid arthritis
2006
Risk of Serious Infections and Malignancies With Anti-TNF Antibody Therapy in Rheumatoid Arthritis—Reply
2006
SAT0539 The Risk of Future Attacks in Patients with Incident Gout: a Population-Based
2013